Recordati Industria Chimica e Farmaceutica S.p.A.
RCDTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $632,321 | $643,882 | $679,960 | $598,478 |
| % Growth | -1.8% | -5.3% | 13.6% | – |
| Cost of Goods Sold | $199,913 | $220,032 | $221,188 | $185,116 |
| Gross Profit | $432,408 | $423,850 | $458,772 | $413,362 |
| % Margin | 68.4% | 65.8% | 67.5% | 69.1% |
| R&D Expenses | $79,812 | $87,001 | $80,117 | $81,177 |
| G&A Expenses | $40,092 | $41,995 | $41,648 | $46,634 |
| SG&A Expenses | $171,379 | $186,982 | $181,390 | $183,653 |
| Sales & Mktg Exp. | $131,287 | $144,987 | $139,742 | $137,019 |
| Other Operating Expenses | $15,575 | $14,602 | $1,499 | $13,773 |
| Operating Expenses | $266,766 | $288,585 | $263,006 | $278,603 |
| Operating Income | $165,642 | $135,265 | $195,766 | $134,759 |
| % Margin | 26.2% | 21% | 28.8% | 22.5% |
| Other Income/Exp. Net | -$20,693 | -$15,774 | -$30,906 | -$29,354 |
| Pre-Tax Income | $144,949 | $119,491 | $164,860 | $105,405 |
| Tax Expense | $34,784 | $28,411 | $39,819 | $27,297 |
| Net Income | $110,165 | $91,080 | $125,041 | $78,108 |
| % Margin | 17.4% | 14.1% | 18.4% | 13.1% |
| EPS | 0.53 | 0.44 | 0.61 | 0.38 |
| % Growth | 20.5% | -27.9% | 60.5% | – |
| EPS Diluted | 0.53 | 0.44 | 0.6 | 0.37 |
| Weighted Avg Shares Out | 206,355 | 206,355 | 206,355 | 206,294 |
| Weighted Avg Shares Out Dil | 209,099 | 209,099 | 209,099 | 209,090 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $23,232 | $24,437 | $26,464 | $21,667 |
| Depreciation & Amortization | $51,137 | $50,721 | $50,922 | $45,431 |
| EBITDA | $219,318 | $194,649 | $242,246 | $172,503 |
| % Margin | 34.7% | 30.2% | 35.6% | 28.8% |